Lai J.-T.Liu C.-L.TIEN-CHEN LIU2020-03-092020-03-0920171749-4478https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018866685&doi=10.1111%2fcoa.12879&partnerID=40&md5=d8fc06029203c9f4203921d1566ae9dchttps://scholars.lib.ntu.edu.tw/handle/123456789/474453[SDGs]SDG3conjugated estrogen; medroxyprogesterone; conjugated estrogen; estrogen; medroxyprogesterone; oral contraceptive agent; adult; auditory threshold; breast tenderness; case study; chronic disease; clinical article; disease severity; disease severity assessment; drug safety; evening dosage; female; follow up; hormone substitution; human; Letter; low drug dose; medical record review; menopause; middle aged; priority journal; pure tone audiometry; recurrent disease; retrospective study; sleep quality; tinnitus; Tinnitus Handicap Inventory; treatment duration; vagina disease; vaginal spotting; visual analog scale; age; chronic disease; tinnitus; Age Factors; Chronic Disease; Contraceptives, Oral, Synthetic; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Menopause; Middle Aged; Retrospective Studies; Tinnitusletter10.1111/coa.12879283467672-s2.0-85018866685